🇺🇸 FDA
Patent

US 10851146

Method for preparing liraglutide intermediate polypeptide

granted A61KA61K38/26

Quick answer

US patent 10851146 (Method for preparing liraglutide intermediate polypeptide) held by AMPHASTAR NANJING PHARMACEUTICALS INC expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AMPHASTAR NANJING PHARMACEUTICALS INC
Grant date
Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/26